Concert Pharmaceuticals Inc (CNCE) Insider Trading
- $10,069,543.44
- $67,321,372.05
- Feb. 15, 2023
- Nancy Stuart
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 18, 2015 | Director | 760,000 | $15.81 | Sell | $12,015,600.00 | |
Aug. 13, 2015 | Director | 92,215 | $16.75 | Sell | $1,544,601.25 | |
Aug. 12, 2015 | Director | 97,785 | $17.49 | Sell | $1,710,259.65 | |
June 8, 2015 | VP | 5,000 | $16.35 | Sell | $81,750.00 | |
March 11, 2015 | COO | 46,430 | $15.00 | Sell | $696,450.00 | |
March 11, 2015 | VP | 5,973 | $16.00 | Sell | $95,568.00 | |
March 10, 2015 | VP | 22,122 | $13.90 | Sell | $307,495.80 | |
Nov. 18, 2014 | Director | 250,000 | $12.29 | Sell | $3,072,500.00 | |
Feb. 20, 2014 | Major Shareholder | 150,000 | $14.00 | Buy | $2,100,000.00 | |
Feb. 19, 2014 | Major Shareholder | 35,000 | $14.00 | Buy | $490,000.00 | |
Feb. 19, 2014 | Director | 89,000 | $14.00 | Buy | $1,246,000.00 |
Insiders are both buying and selling Concert Pharmaceuticals Inc stock.
The insider traders at Concert Pharmaceuticals Inc are: Nancy Stuart, Richard Aldrich, Wilfred E Jaeger, Roger D Tung, Jeffrey A Munsie, Thomas G Auchincloss, Heek Christi Van, Pauline Mcgowan, James V Cassella, Peter Barton Hutt, Value Fund L P Biotechnology, Robert Silverman, Three Arch Management Iv, L.L., Marc A Becker, Bvf Partners L P/Il, Plc Glaxosmithkline, Life Science Ventures Vi G Tvm, Ronald W Barrett, Ronald W. Barrett, Ryan Lynch, and Skyline Venture Partners Quali
The most active insider trader at Concert Pharmaceuticals Inc is Nancy Stuart with 10 trades.
Value Fund L P Biotechnology has sold the most Concert Pharmaceuticals Inc stock with a total value of $68,376,224.80.
Value Fund L P Biotechnology has bought the most Concert Pharmaceuticals Inc stock with a total value of $10,515,098.88.
The most recent insider trade for Concert Pharmaceuticals Inc was on Feb. 15, 2023.
The single biggest insider buy for Concert Pharmaceuticals Inc was from Value Fund L P Biotechnology with a total value of $5,257,549.44 on Oct. 19, 2017.
The single biggest insider sell for Concert Pharmaceuticals Inc was from Value Fund L P Biotechnology with a total value of $34,188,112.40 on Dec. 19, 2017.